Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Proprietary Chinese medicine for treating ulcerative colitis

A technology of ulcerative colitis and Chinese patent medicine, applied in the direction of drug combination, medical formula, heavy metal active ingredients, etc., can solve the problems of unsatisfactory curative effect, unknown etiology, and inability to effectively cut off the pathological development trend of the disease

Inactive Publication Date: 2009-09-16
李怀涛
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Ulcerative colitis, also known as non-specific ulcerative colitis, is an inflammatory disease of the rectum and colon with unknown etiology. The lesions are mainly limited to the mucosa and submucosa of the large intestine. The clinical manifestations include diarrhea, mucus pus and blood in the stool, abdominal pain and tenesmus. The severity varies, and most of them have an active period and a remission period, showing a repeated chronic course (see "Internal Medicine" published by People's Health Publishing House, edited by Chen Haozhu, the fourth edition in August 1997, page 374, chapter nine). So far, The current Western medicine treatment of this disease is mostly symptomatic treatment. If diarrhea and abdominal pain are obvious, atropine, anti-inflammatory drugs, and sulfasalazine are given as the first choice. They must be taken for 1-2 years. For severe cases, adrenocorticosteroids should be used. Even surgical treatment is used, which shows that these treatments cannot effectively cut off the pathological development trend of the disease, and cannot cure the disease at the initial stage, but make the disease a chronic and protracted process.
In terms of traditional Chinese medicine, there are not many existing Chinese patent medicines that are clearly targeted, and the curative effect is not satisfactory. In terms of traditional Chinese medicine decoctions, not to mention the difficulty in syndrome differentiation, because the disease is extremely lingering, it is very inconvenient to take decoctions for a long time Furthermore, the advantage of TCM syndrome differentiation and treatment is that it has a more detailed understanding of the cross-section of a certain period of the disease, and often ignores the integrity of the vertical development of the disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Proprietary Chinese medicine for treating ulcerative colitis
  • Proprietary Chinese medicine for treating ulcerative colitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0040]Example: Take Cimicifuga 18 Angelica 18 Astragalus 20 Aconite 20 Hawthorn 20 Licorice 25 Pulsatilla 40 Sophora flavescens 20 Scutellaria baicalensis 40 Burnet 20 Red stone fat 60 Angelica 20 Frankincense 15 Myrrh 15 Paeoniae Alba 20 Gallus chinensis 12 Betel nut 20 Agrimony 20

[0041] Break into pieces with a pulverizer and pass through a 120-mesh sieve to make water pellets with 10 grains per gram. Take 7 grams each time, three times a day, after meals. Seven days a course of treatment, generally take 1-6 courses of treatment can be cured.

[0042] Table 1 The curative effect of the control group

[0043]

[0044] Table 2 The curative effect of the experimental group

[0045]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a prepared traditional Chinese medicinal preparation for treating ulcerative colitis, wherein the raw materials include cimicifuga rhizome, dahurian angelica root, astragalus root, prepared aconite root, haw, licorice root, Chinese pulsatilla root, flavescent sophora root, baikal skullcap root, garden burnet root, red halloysite, Chinese angelica root, frankincense, myrrh, root of herbaceous peony, chicken's gizzard-skin, areca-nut and hairy vein agrimony.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a Chinese patent medicine for treating ulcerative colitis. Background technique [0002] Today's world economy is developing rapidly, people's pace of life is getting faster and faster, everyone is facing more and more social pressure, and the number of sub-health groups is increasing. With the enrichment of material life, the diversification of diet documents, and the Compared with the traditional era, the "toxicity" of diet has increased, resulting in more and more patients with the so-called "disease of affluence". Ulcerative colitis can also be counted as one of the "diseases of affluence". [0003] Ulcerative colitis, also known as non-specific ulcerative colitis, is an inflammatory disease of the rectum and colon with unknown etiology. The lesions are mainly limited to the mucosa and submucosa of the large intestine. The clinical manifestations include diarrhea,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/889A61K36/739A61K36/734A61K36/73A61K36/714A61K36/71A61K36/539A61K36/489A61K36/484A61K36/481A61K36/328A61K36/324A61K36/232A61K35/37A61K33/26A61P1/00A61P1/04A61K35/57
Inventor 李怀涛
Owner 李怀涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products